The latest in the deals space in India has seen Pharmaceutical firm Jubilant Life Sciences Ltd has raised Rs 100 crore ($15.5 million) through the issue of commercial papers even as Warburg Pincus is looking to sell its 10 per cent stake in Capital First.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
